Shamburg News · 8-K filed Nov 5, 2026, 4:15 PM EST

Profound Medical Reports Q3 2026 Revenue of $9.8 Million and Announces CEO Succession

PROF · Profound Medical Corp.

  • Earnings
  • Leadership change
  • Materiality: high

Profound Medical Corp. reported financial results for the quarter ended September 30, 2026, with total revenue of approximately $9.8 million, up 86% year-over-year, and a net loss of approximately $7.7 million, or $0.21 per common share. The company projects full-year 2026 revenue of at least $25.0 million. Richard Fabian will succeed Arun Menawat as CEO effective January 14, 2027, Matthew Sobczyk was appointed permanent CFO, and Jason Mills was appointed to the Board.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 5.02, 9.01, accession 0001171843-26-007182.

Written from the filing by Shamburg Markets. Figures are as reported by the company.